CEREPAK FREEFORM XCR123575Recalls & reported problems
Cerenovus, Inc. · CEREPAK FREEFORM XtraSoft Detachable Coil Delivery System Length - 190 cm Coil Diameter - 3.5 mm Coil Length - 7.5 cm · Class 2 · Implant
All models of CEREPAK FREEFORM (60)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10886704083788), received between Mar 21, 2024 and Oct 22, 2024 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Separation Failure” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Oct 2, 2025Class IOpen, Classified
Detachable coils system may fail to detach, which could result in hemorrhagic and ischemic stroke, procedural delays, or the need for additional surgical intervention.
Z-0434-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Separation Failure2
- Break1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 22, 2024Separation Failure; Separation Failure
THE HEALTHCARE PROFESSIONAL REPORTED THAT DURING AN ENDOVASCULAR EMBOLIZATION PROCEDURE, THE 3MM X 8CM CEREPAK FREEFORM (XCR123575 / 31178188) DID NOT DEPLOY AFTER MULTIPLE ATTEMPTS. THE PROCEDURE WAS DELAYED BY 20 MINUTES. THE COIL WAS REMOVED AND A NEW COIL WAS INTRODUCED. THERE WAS NO REPORT OF ANY NEGATIVE PATIENT IMPACT. ON 07-OCT-2024, ADDITIONAL INFORMATION WAS RECEIVED. PER THE INFORMATION, THE PROCEDURE WAS TARGETING A 4.3MM X 4.6MM X 5.2MM UNRUPTURED ANEURYSM LOCATED ON THE LEFT M1/M2 BIFURCATION. THE DETACHMENT ATTEMPTS WERE MADE TWO TIMES VIA THE DETACHMENT HANDLE (MDH1 / 102109430) AND TWICE VIA THE MANUAL BREAK TECHNIQUE. WHEN THE COMPLAINT COIL WAS REMOVED, IT WAS STILL ATTACHED TO THE DELIVERY SYSTEM AND IT WAS NOT STRETCHED. THE MICROCATHETER USED WAS A STRAIGHT TIP EXCELSIOR® SL-10® MICROCATHETER (STRYKER). THE REPLACEMENT COIL WAS A 3MM X 6CM CEREPAK FREEFORM XTRASOFT (XCR120306). THE INFORMATION CONFIRMED THERE WAS NO NEGATIVE PATIENT IMPACT. PER THE INFORMATION, THE PHYSICIAN DID NOT CONSIDER THE REPORTED 20-MINUTE DELAY TO BE CLINICALLY SIGNIFICANT, BUT ¿SHE DID NOT APPRECIATE THE DELAY AND HAVING TO REMOVE THE COIL, TO SWITCH OUT FOR DIFFERENT COIL. BEING THA
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20502164 ↗MalfunctionMar 21, 2024Break; Separation Failure; Break; Separation Failure
THE HEALTHCARE PROFESSIONAL REPORTED THAT DURING A COIL EMBOLIZATION PROCEDURE TARGETING AN ANEURYSM ON THE MIDDLE CEREBRAL ARTERY (MCA), THE 3MM X 8CM CEREPAK FREEFORM COIL (XCR123575 / 31178188) WAS DEPLOYED INTO THE ANEURYSM AND SUBSEQUENTLY DID NOT DETACH WITH MANUAL DETACHMENT. WHEN THE PHYSICIAN TRIED TO PULL THE WIRE AGAIN UPON RE-DEPLOYMENT, THE WIRE BROKE. THE COIL WAS REMOVED. THE NEXT COIL, A 3MM X 8CM CEREPAK FREEFORM XSFT (XCR120308 / 31112709) WAS ADVANCED, BUT THE DELIVERY WIRE BECAME BENT AND IT WAS REMOVED WITHOUT DEPLOYMENT. TWO MORE COILS WERE PLACED WITHOUT DIFFICULTY AND THE CASE WAS SUCCESSFULLY COMPLETED. THERE WAS NO REPORT OF ANY NEGATIVE PATIENT IMPACT. ON 06-MAR-2024, ADDITIONAL INFORMATION WAS RECEIVED. PER THE INFORMATION, IT IS NOT KNOWN IF THE COIL WAS STRETCHED WHEN IT WAS REMOVED BECAUSE ¿IT WAS PULLED THROUGH THE RHV.¿ THE COIL WAS STILL ATTACHED TO THE DELIVERY SYSTEM WHEN IT WAS REMOVED. THE CONCOMITANT MICROCATHETER USED WAS A 150CM X 50CM PROWLER 14 (606151FX / LOT# UNKNOWN); THE SAME MICROCATHETER WAS USED WITH THE NEXT COIL, 3MM X 8CM CEREPAK FREEFORM XSFT (XCR120308 / 31112709). A CONTINUOUS FLUSH HAD BEEN MAINTAINED THROUGH THE MICROCATHETE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18956557 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page